tbuckley/cabot-search huggingface dataset:
The Journal’s Progress
Authors: Lee Baer, Douglas G. Jacobs, Joelle Meszler-Reizes, Mark Blais, Maurizio Fava, Ronald Kessler, Kathryn Magruder, Jane Murphy, Barbara Kopans, Peter Cukor, Linda Leahy, John O'Laughlen, Anabel Martínez-Arán, Eduard Vieta, Francesc Colom, María Reinares, Antoni Benabarre, Cristòbal Gastó, Manel Salamero, Amanda J. Gruber, Harrison G. Pope Jr., Diana De Ronchi, Ambra Muro, Alba Marziani, Paola Rucci, H. Lazaratou, M. Vlassopoulos, G. Dellatolas, Patricia L. Dobkin, Frank A. Treiber, Richard E. Tremblay
Journal: Psychotherapy and Psychosomatics (1999)
Availability of Sulfadiazine—United States
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Propoxyphene jaundice
Authors: G. K. Daikos
Journal: JAMA (1975)

TO OUR knowledge, propoxyphene (dextropropoxyphene), a widely used analgesic, has been demonstrated as hepatotoxic in regular clinical use only once.<sup>1</sup>We wish to report another case of jaundice apparently caused by this drug. <h3>Report of Case</h3> On Nov 20, 1970, a 47-year-old man who had been suffering from sciatic pains for several years started taking a combination of orphenadrine citrate (35 mg), and paracetamol (450 mg) (Norgesic, as available in Greece), six to eight tablets daily, as well as propoxyphene hydrochloride (65 mg) (Doloxene, as available in Greece), three to four capsules daily. Three days later, he suddenly experienced an extremely severe upper abdominal pain of short duration, followed the next morning by dark urine, clay-colored stools, and gradual development of jaundice. No anorexia, nausea, or other gastrointestinal symptoms preceded or accompanied this episode, and the patient's temperature was normal. On examination, the liver was palpable 1 1/2 finger
A CASE OF CEREBELLAR ABSCESS WITH VERY UNUSUAL FEATURES; OPERATION; RECOVERY
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Investigating Hypertension
Authors: P. W. Robertson
Journal: BMJ (1967)

Investigating HypertensionSno-Your recent leading article (1 July, p. 4) entitled " Investigating Hypertension" appears to give a somewhat incomplete and Bmseading impression of the current position in this field.Indeed, it is a little difficult to see what point your writer is trying to make.When is investigation of hypertension "fruitless " ?Apparently when continued
Dr. Garcelon Was Not Officer of American Medical Association
Journal: JAMA (1935)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Burns: Types, Pathology and Management.
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis
Authors: E Argao
Journal: Hepatology (1994)

Almost all infants and children with chronic cholestasis have osteopenia. We evaluated the effect of orthotopic liver transplantation on bone mineral content and serum 25(OH)-vitamin D–[25(OH)D]–of nine infants and children (five girls; age, 6 to 21 mo at the time of orthotopic liver transplantation) with end-stage liver disease resulting from chronic cholestasis. We hypothesized that after orthotopic liver transplantation, decreased bone mineral content will recover and the serum 25(OH)D level will either normalize or remain normal in those who were previously vitamin D deficient or sufficient, respectively. All had subnormal bone mineral content before transplant. On long-term follow-up (>4 mo) of seven patients, bone mineral content normalized in all between 6.5 and 19 mo after transplant, with a mean of 11.2 + 4.5 mo. In six patients with normal serum 25(OH)D levels before orthotopic liver transplantation, the serum 25(OH)D levels had declined markedly 1 to 2 mo after transplant, followed by return to normal by 3 to 6 mo. Low serum 25(OH)D levels (<15 ng/ml) in three patients before orthotopic liver transplantation normalized after transplant. Although there was no correlation between bone mineral content and serum 25(OH)D level before transplant, sustained normal serum 25(OH)D and 1,25(OH)2D levels preceded or accompanied normalization of bone mineral content in the seven patients available for long-term follow-up. We conclude that (a) in infants and children younger than 2 yr with chronic cholestasis, bone mineral content normalizes approximately 11 mo after orthotopic liver transplantation. This normalization is preceded by a sustained period of normal serum 25(OH)D levels. (b) Normal baseline serum 25(OH)D levels decrease 1 to 2 mo after orthotopic liver transplantation, with subsequent normalization, whereas initially low serum 25(OH)D levels gradually normalize within 2 to 4 mo. We speculate that maintenance of normal serum 25(OH)D levels with oral vitamin D supplementation may enhance recovery of bone disease after orthotopic liver transplantation. (HEPATOLOGY 1994;20:598–603).
Congenital deficiency of fibrin-stabilizing factor. Report of a case and family study
Authors: M. Zahir
Journal: JAMA (1969)

A 3-year-old girl had a deficiency in fibrin-stabilizing factor (factor XIII). Although approximately 18 cases of this disorder have been reported in the world literature, the present case is of interest for three reasons: (1) A factor XIII level of 1% to 2% was sufficient to correct the defect in the patient's plasma. (2) There was a history of intermarriage between relatives in the patient's family. (3) A partial deficiency of factor XIII was demonstrated in the patient's parents and in some of the other members of her family.
THE PURIFICATION OF SURFACE WATER-SUPPLIES.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
IEEE Reviews on Biomedical Engineering publication information
Authors: Stephen Welby, Julie Eve, Jack Bailey, Jamie Moesch, Karen Hawkins, Cecelia Jankowski, Konstantinos Karachalios, Ljiljana Trajkovic, Toshio Fukuda, Susan Kathy" Land, Kathleen Kramer, Joseph Lillie, José Moura, Tapan Sarkar
Journal: IEEE Reviews in Biomedical Engineering (2021)
Neurological surgery
Authors: R. H. Wilkins
Journal: JAMA (1992)

In their 1990 Contempo issue report, Carson and Brem emphasized that neurological surgery has rapidly evolved into a high-tech specialty.<sup>1</sup>They mentioned the development by neuroradiologists and neurosurgeons of the subspecialty of interventional neuroradiology and discussed the endovascular treatment of such lesions as intracranial aneurysms and arteriovenous malformations using balloons, glues, etc. Further refinements in equipment and technique have extended this work, with greater success and fewer complications. These interventionalists are now able to guide their catheters safely into small cerebral arterial branches to perform diagnostic and therapeutic maneuvers that include selective angiography; injection of an agent such as amobarbital to transiently alter the function of a focal brain region to establish the location of certain functions such as speech; injection of a chemotherapeutic drug into the direct arterial supply of a tumor; injection of an agent such as tissue plasminogen activator to lyse intravascular emboli and thrombi; injection
Neurophthalmological Diagnosis
Authors: Gordon J. Gilbert
Journal: JAMA (1974)

<h3>To the Editor.—</h3> In your QUESTIONS AND ANSWERS of Oct 15 (226:364, 1973), Dr. William Conway's 69-year-old patient experienced first a pain in his right eye and several days later acute onset of visual blurring in the same eye. Within the next few months he had several episodes of numbness on the right side of his body. Dr. Conway asked what further studies should be done, and your consultant, Dr. David Shoch, recommended a careful neurophthalmological examination with particular attention to the visual fields. Presumably, a careful neurophthalmological examination would include auscultation for bruits over the carotid arteries and orbits; it seems particularly important to rule out bilateral internal carotid artery stenosis. The patient's attack of right-sided numbness would be consistent with left carotid stenosis with cerebral microemboli, while the attack of acute right amaurosis would be consistent with a similar process involving the right internal carotid artery. Monocular amblyopia
The House of Delegates
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Scandinavian Leprosy.
Authors: Albert S. Ashmead
Journal: JAMA (1900)

New York City, July 2, 1900. <h3>To the Editor:</h3> —Referring to your encouraging remarks on "Leprosy in Wisconsin," which appeared inThe Journalof June 30, will you permit me to say that no one disputes the proposition that if time enough be given, leprosy will eradicate itself by death of the patient. Hansen said in the Berlin Leper Conference: "Wait fifteen years and your German lepers of Memel will be dead." But why did it require so much longer to eradicate leprosy from his own country? Because his isolation there was two-thirds in families and but one-third in hospitals. Had he instituted perfect isolation, perhaps his fifteen years' limit would have been sufficient. You state that Dr. Wingate said that the germ of the disease appears in his climate to find little suitable soil in the nativeborn population, at least up to date, etc. Let me inform you —perhaps
The Western Interstate Plan
Authors: K. P. Bunnell
Journal: JAMA (1969)

For the past 15 years, the Western Interstate Commission for Higher Education (WICHE) has been carrying forward its responsibility to foster cooperation among the 13 western states for the improvement of higher education. The commission sponsors a wide range of cooperative programs, including those to strengthen nursing, mental health, university management information systems, social work, and medical education. At present, several of WICHE's programs are designing new approaches to health manpower production. One such program, still in the planning stage, would provide facilities for the education of physicians and related personnel in the western intermountain region. The concept envisions the use of multiple university campuses for basic science instruction and widely separated community hospitals for clinical instruction. This effort would be supplemented by the use of self-instructional devices and communications networks. <h3>WICHE and Medical Education</h3> In its early years, WICHE conducted studies of physician manpower in the West. These studies
Angiology, Baltimore
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Consideration of Factors Responsible for Stomal Obstruction Following a Billroth I Anastomosis
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The "Anti-Brain" Factor in Psychiatric Patients' Sera
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
Authors: C. Lin, C. Hsu, J. C. Cheng, C. Yen, H. Shiah, J. Lee, H. Wang, K. Yeh, A. Cheng, Y. Lee
Journal: Journal of Clinical Oncology (2011)

79 Background: We investigated the efficacy and safety of adding cetuximab into twice-weekly paclitaxel/cisplatin-based concurrent chemoradiotherapy (CCRT), followed by surgery, for patients with locally advanced esophageal squamous cell carcinoma (ESCC). Methods: Patients with operable ESCC (T3N0-1M0 or T1-3N1M0 or M1a) were treated with paclitaxel (35 mg/m 2 1 h on days 1 and 4/week), cisplatin (15 mg/m 2 1 h on days 2 and 5/week), cetuximab (400 mg/m 2 2 h on day -5, then 250 mg/m 2 2 h on day 3/week) and radiotherapy (2 Gy on days 1-5/week). When the accumulated radiation dose reached 40 Gy, the feasibility of esophagectomy was evaluated for all patients. In patients for whom esophagectomy was not feasible, CCRT was continued to a radiation dose of 60-66 Gy. Results: Sixty-two patients with ESCC were enrolled, and the majority had T3N1M0 or M1a tumors by endoscopic ultrasonographic staging (94%). All patients received CCRT to 40 Gy. Forty-three patients underwent surgery, and 17 patients continued definitive CCRT to 60-66 Gy. Of the scheduled doses of paclitaxel, cisplatin, and cetuximab, 80%, 79%, and 99% were given, respectively. The intent-to-treat pathological complete response rate was 24% (15/62) (95% confidence interval: 13-35%). At the median follow-up of 13.3 months, the one-year progression-free and overall survivals were 76% and 63%, respectively. The most common grade 3/4 toxic effects were leukopenia (51%), neutropenia (15%), esophagitis (19%), and infection (12%). Grade 1, 2, and 3 skin rash occurred in 59%, 36%, and 2% of patients, respectively. Grade 1, 2, 3, and 4 hypomagnesemia occurred in 14%, 5%, 0%, and 5% of patients, respectively. Conclusions: Adding cetuximab to twice-weekly paclitaxel/cisplatin-based CCRT prior to esophagectomy is an active and tolerable treatment for locally advanced ESCC. No significant financial relationships to disclose.
Implementation of a Standardized Clinical Assessment and Management Plan (SCAMP) for Food Challenges
Authors: Tander Simberloff, Ron Parambi, Lisa Bartnikas, Ana Dioun Broyles, Victoria Hamel, Karol G. Timmons, D. Marlowe Miller, Dionne Graham, Lynda C. Schneider, Andrew J. MacGinnitie
Journal: Journal of Allergy and Clinical Immunology (2016)